CN112791143A - 一种止血生肌药物 - Google Patents

一种止血生肌药物 Download PDF

Info

Publication number
CN112791143A
CN112791143A CN202110268300.8A CN202110268300A CN112791143A CN 112791143 A CN112791143 A CN 112791143A CN 202110268300 A CN202110268300 A CN 202110268300A CN 112791143 A CN112791143 A CN 112791143A
Authority
CN
China
Prior art keywords
parts
medicine
stopping bleeding
tissue regeneration
promoting tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110268300.8A
Other languages
English (en)
Inventor
祝蓓蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Deshan Tea Culture Co ltd
Original Assignee
Shaanxi Deshan Tea Culture Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Deshan Tea Culture Co ltd filed Critical Shaanxi Deshan Tea Culture Co ltd
Priority to CN202110268300.8A priority Critical patent/CN112791143A/zh
Publication of CN112791143A publication Critical patent/CN112791143A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/241Lead; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/28Mercury; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种止血生肌药物,其由石膏、轻粉、赤石脂、黄丹、龙骨、血竭、乳香、樟脑组成。本发明各组分合理配伍,且相互之间协同作用能够起到快速止血、加速收敛,促进伤口愈合的功效,其对于一些手术创口能够起到显著的止血收敛效果,尤其是对于痔疮手术或痔疮唇系带微创手术。

Description

一种止血生肌药物
技术领域
本发明涉及药物技术领域,具体是指一种止血生肌药物。
背景技术
痔疮是最常见的肛肠疾病,任何年龄段均可能发病。由于痔疮的发病部位比较特殊,患者往往难以启齿,拖延治疗,导致病情加重,其实大可不必,及早接受治疗不仅可尽早恢复,还能减轻痛苦。目前对痔疮的治疗可采用手术或微创手术进行,为了手术伤口尽快恢复,将其影响降低最低,因此需要辅以能够快速止血生肌,加速伤口愈合的药物。
发明内容
因此,基于以上背景,本发明提供一种止血生肌药物,其能够起到快速止血,加速收敛,促进伤口愈合,尤其是针对痔疮手术或微创手术伤口,缩短伤口愈合时间,降低手术对患者生活的影响。
本发明的技术方案为:
一种止血生肌药物,其由以下组分组成:
石膏、轻粉、赤石脂、黄丹、龙骨、血竭、乳香、樟脑。
进一步地,其由以下重量份组分组成:
石膏30份、轻粉30份、赤石脂30份,黄丹6份,龙骨9份、血竭9份、乳香9份、樟脑9份。
进一步地,在使用时,先将配方材料磨成粉,然后将其干掺到由甘草、当归、白芷各3份进行煎煮的药液中,然后用软油纸盖扎进行备用即可。
本方剂中的石膏具有清热泻火,除烦止渴等功效;轻粉外用具有杀虫,攻毒,敛疮等功效;赤石脂具有涩肠,止血,生肌敛疮等功效;黄丹外用具有拔毒生肌,杀虫止痒等功效;龙骨具有镇惊安神,敛汗固精,止血涩肠,生肌敛疮等功效;血竭具有祛瘀定痛,止血生肌等功效;乳香具有调气活血,定痛,追毒等功效;樟脑具有通窍,杀虫,止痛,辟秽等功效。。
本发明与现有技术相比的优点在于:
本发明各组分合理配伍,且相互之间协同作用能够起到①缩短血液凝血时间、伤口出血时间及凝血酶原时间,对动脉血管条有收缩作用。②对人体毛细血管急性血栓形成抵抗作用,不会出现血管内异常凝血。③对于创伤性疼痛、痛经和炎症等起到不错的效果。④有抑菌作用,防止创伤的感染等作用,具有活血祛腐,生肌敛疮等功效,可用于治疗痈疽疮疖,诸种溃疡,疮口腐肉已脱,脓水将尽等病症,临床上还可以用于治疗宫颈糜烂、溃疡性结肠炎等。其对于一些手术创口能够起到显著的止血收敛效果,尤其是对于痔疮的微创手术。
具体实施方式
下面结合实施例对本发明一种治疗咽喉炎的中药制剂做进一步的详细说明。
实施例1:一种止血生肌药物,其由以下组分组成:石膏30克、轻粉30克、赤石脂30克,黄丹6克,龙骨9克、血竭9克、乳香9克、樟脑9克。
在使用时,先将配方材料磨成粉,然后将其干掺到由甘草、当归、白芷各3克进行煎煮的药液中,然后用软油纸盖扎进行备用即可。
实施例2:典型病例
案例1:李某,女,35岁,福建漳州人,2011年来就诊时自述大便时伴有便血,肛周瘙痒,坠胀不适不舒服,经医院确诊其患有痔疮。其来我处进行微创唇系带手术,通过对唇系带上的标示痔疮病灶的结节进行切除,然后将本发明的药物外敷至微创手术创口,伤口在1分钟内即可停止出血。采用此方法对痔疮进行治疗后,可通过将痔疮病灶进行彻底消除,实现痔疮根治。
上述的微创唇系带手术的方法为:观察病患上唇系带龈交穴上的点状结节,点状结节标示有痔核,一个小点标示一个痔,小点数量与所罹患痔核数成正比,且小点位置标示了痔疮在肛内的位置,采用剪刀或镊子将结节进行切除,即可将痔疮病灶进行切除。
中医学认为,人体是一个整体全身经络而互相联系起来。经络沟通人组织器官和运行气血精津,把人体构成有机的统一整体。在病理条件下,经络成为病症的反应系统。而根据达尔文医学理论,从系统发生的角度看,上唇系带与肛垫具有相关性,其相关性源于摄食与排泄原始口肛结构功能的统一性。
而上唇系带位于上唇内面正中,上端与上唇、下端与齿龈相连。正是龈交穴位置所在。龈交穴属于督脉,该穴位位于上唇系带与牙齿移行处,是督脉的止脉,也是督脉、手阳明经、任脉等静脉的交汇处。根据经络学说,上唇系带龈交穴痔反应点位于督脉,肛门部亦处于督脉,因此,在诊断痔瘘病时,可以通过检查上唇系带龈交穴的变化来判断,也可通过对上唇系带的微创手术来实现痔瘘的根治。
案例2:陈某,男,44岁,福建莆田人,自述喜食辛辣食物,2010年来就诊时,自述2个月前,大便不畅,用力痔核外翻,甚至脱出,并且肿胀疼痛,经医院已经确诊患有痔疮。其来我处进行微创唇系带手术,通过对唇系带上的标示痔疮病灶的结节进行切除,然后将本发明的药物外敷至微创手术创口,伤口在1分钟内即可停止出血,然后在患者的肛门处另外外敷痔疮膏,持续7天后,痔核脱落,痔疮痊愈。至今,其痔疮未出现复发。
以上对本发明及其实施方式进行了描述,这种描述没有限制性。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。

Claims (3)

1.一种止血生肌药物,其特征在于,其由以下组分组成:
石膏、轻粉、赤石脂、黄丹、龙骨、血竭、乳香、樟脑。
2.根据权利要求1所述的一种止血生肌药物,其特征在于,其由以下重量份组分组成:
石膏30份、轻粉30份、赤石脂30份,黄丹6份,龙骨9份、血竭9份、乳香9份、樟脑9份。
3.根据权利要求1或2所述的一种止血生肌药物,其特征在于,在使用时,先将配方材料磨成粉,然后将其干掺到由甘草、当归、白芷各3份进行煎煮的药液中,然后用软油纸盖扎进行备用即可。
CN202110268300.8A 2021-03-12 2021-03-12 一种止血生肌药物 Pending CN112791143A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110268300.8A CN112791143A (zh) 2021-03-12 2021-03-12 一种止血生肌药物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110268300.8A CN112791143A (zh) 2021-03-12 2021-03-12 一种止血生肌药物

Publications (1)

Publication Number Publication Date
CN112791143A true CN112791143A (zh) 2021-05-14

Family

ID=75817045

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110268300.8A Pending CN112791143A (zh) 2021-03-12 2021-03-12 一种止血生肌药物

Country Status (1)

Country Link
CN (1) CN112791143A (zh)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周德生等: "《中风病良方大全》", 31 January 2016 *

Similar Documents

Publication Publication Date Title
CN110292602A (zh) 一种复方五黄烧伤油配方及其制备方法
CN100372562C (zh) 一种褥疮膏及其制备方法
CN102274371A (zh) 一种治疗烧烫伤、外伤感染、褥疮的药膏
CN108186840A (zh) 一种治疗创伤蕴毒腐溃疼痛症的中药药膏及其制作方法
CN101264196B (zh) 用于治疗外科伤口的外用药物组合物及其膏剂的制备方法
CN102861151B (zh) 一种治疗褥疮的中药组合物
CN103566071B (zh) 一种治疗溃疡的外用中药组合物及其散剂的制备方法
CN101002866B (zh) 一种治疗动物外伤的中药
CN102716281B (zh) 一种用于术后伤口清洗的护理液
CN112791143A (zh) 一种止血生肌药物
AU2021103356A4 (en) External use medicine for reviving cortical tissue of scalds and burns and its preparation method
CN105250712B (zh) 一种治疗褥疮的中药组合物
CN113908220A (zh) 一种湿润烧伤膏及制备方法
CN101647952A (zh) 外用生肌收口药
CN101653541A (zh) 用于治疗烧烫伤的药物制剂
CN104083421A (zh) 治疗褥疮的中药药膏及其制备方法
CN111603537B (zh) 一种治疗痈疽疮疡的中药组合物、油剂及制备方法和应用
CN109045204A (zh) 一种治疗烧伤和烫伤的中药液及其制备方法
CN103565921A (zh) 一种治疗褥疮以及伤口快速愈合特效药
CN108210548A (zh) 用于外伤创面的中药药膏及其制备方法
CN106511676A (zh) 一种临床护理上用于治疗褥疮的中药组合物
CN101869578B (zh) 拔毒消炎外用擦剂
CN105832909A (zh) 一种治疗皮肤坏死性溃疡的中药制剂
CN105726972A (zh) 一种促进伤口愈合并抑制疤痕形成的中草药组合物及其制作方法和用途
CN104398823A (zh) 一种治疗ⅱ度烧伤的中药膏剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210514

RJ01 Rejection of invention patent application after publication